185 related articles for article (PubMed ID: 20126828)
1. Coagulation disorders and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
Thromb Haemost; 2010 Feb; 103(2):299-305. PubMed ID: 20126828
[TBL] [Abstract][Full Text] [Related]
2. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.
Kuhli C; Scharrer I; Koch F; Ohrloff C; Hattenbach LO
Am J Ophthalmol; 2004 Mar; 137(3):459-64. PubMed ID: 15013868
[TBL] [Abstract][Full Text] [Related]
3. [Selective thrombophilia screening of young patients with retinal vein occlusion].
Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
Klin Monbl Augenheilkd; 2009 Sep; 226(9):768-73. PubMed ID: 19399710
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of resistance to APC in young patients with retinal vein occlusion.
Kuhli C; Hattenbach LO; Scharrer I; Koch F; Ohrloff C
Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
[TBL] [Abstract][Full Text] [Related]
6. Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion.
Kuhli-Hattenbach C; Miesbach W; Lüchtenberg M; Kohnen T; Hattenbach LO
Acta Ophthalmol; 2017 Mar; 95(2):140-145. PubMed ID: 27545749
[TBL] [Abstract][Full Text] [Related]
7. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management.
Yau JW; Lee P; Wong TY; Best J; Jenkins A
Intern Med J; 2008 Dec; 38(12):904-10. PubMed ID: 19120547
[TBL] [Abstract][Full Text] [Related]
8. Familial thrombophilia and retinal vein occlusion.
Backhouse O; Parapia L; Mahomed I; Lee D
Eye (Lond); 2000 Feb; 14 ( Pt 1)():13-7. PubMed ID: 10755093
[TBL] [Abstract][Full Text] [Related]
9. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C resistance is a risk factor for central retinal vein occlusion.
Marcucci R; Bertini L; Liotta AA; Rogolino A; Antonucci E; Ilari I; Pepe G; Prisco D
Ann Ital Med Int; 2000; 15(3):195-8. PubMed ID: 11059059
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic risk factors in patients with central retinal vein occlusion.
Marcucci R; Bertini L; Giusti B; Brunelli T; Fedi S; Cellai AP; Poli D; Pepe G; Abbate R; Prisco D
Thromb Haemost; 2001 Sep; 86(3):772-6. PubMed ID: 11583306
[TBL] [Abstract][Full Text] [Related]
12. [Thrombophilia - a risk factor of retinal vein occlusion?].
Karska-Basta I; Kubicka-Trzaska A; Romanowska-Dixon B; Undas A
Klin Oczna; 2013; 115(1):29-33. PubMed ID: 23882736
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome in patients with retinal venous occlusion.
Paccalin M; Manic H; Bouche G; Landron C; Mercié M; Boinot C; Gombert JM; Roblot P; Dighiero P
Thromb Res; 2006; 117(4):365-9. PubMed ID: 16461072
[TBL] [Abstract][Full Text] [Related]
14. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
[TBL] [Abstract][Full Text] [Related]
15. [Thrombophilic and systemic risk factors in patients with retinal vein occlusion].
Kuhli-Hattenbach C; Miesbach W; Scharrer I; Hattenbach LO
Ophthalmologe; 2011 Feb; 108(2):104-10. PubMed ID: 21287178
[TBL] [Abstract][Full Text] [Related]
16. The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.
Rehak M; Krcova V; Slavik L; Fric E; Langova K; Ulehlova J; Rehak J
Can J Ophthalmol; 2010 Apr; 45(2):171-5. PubMed ID: 20379305
[TBL] [Abstract][Full Text] [Related]
17. Protein Z levels and central retinal vein or artery occlusion.
Koren-Michowitz M; Eting E; Rahimi-Levene N; Garach-Jehoshua O; Volcheck Y; Kornberg A
Eur J Haematol; 2005 Nov; 75(5):401-5. PubMed ID: 16191090
[TBL] [Abstract][Full Text] [Related]
18. [The contribution of the hematological examination in patients with retinal vein occlusion].
Kovácová M; Pochop P; Hochová I; Dottelová D; Darsová D
Cesk Slov Oftalmol; 2007 May; 63(3):193-8. PubMed ID: 17621835
[TBL] [Abstract][Full Text] [Related]
19. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
20. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Pinna A; Carru C; Solinas G; Zinellu A; Carta F
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
